ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells

Simonetta Bacci, Rosa Di Paola, Claudia Menzaghi, Patrizia Di Fulvio, Sara Di Silvestre, Fabio Pellegrini, Roberto Baratta, Antonella Marucci, Sandra Mastroianno, Grazia Fini, Gloria Formoso, Agostino Consoli, Francesco Perticone, Lucia Frittitta, Assunta Pandolfi, Vincenzo Trischitta

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

OBJECTIVE-: Insulin resistance induces increased pulse pressure (PP), endothelial dysfunction (ED), and reduced bioavailability of endothelium-derived nitric oxide (NO). The genetic background of these 3 cardiovascular risk factors might be partly common. The ENPP1 K121Q polymorphism is associated with insulin resistance and cardiovascular risk. METHODS AND RESULTS-: We investigated whether the K121Q polymorphism is associated with increased PP in white Caucasians and with ED in vitro. In 985 individuals, (390 unrelated and 595 from 248 families), the K121Q polymorphism was associated with PP (P=8.0×10). In the families, the Q121 variant accounted for 0.08 of PP heritability (P=9.4×10). This association was formally replicated in a second sample of 475 individuals (P=2.6×10) but not in 2 smaller samples of 289 and 236 individuals (P=0.49 and 0.21, respectively). In the individual patients' data meta-analysis, comprising 1985 individuals, PP was associated with the Q121 variant (P=1.2×10). Human endothelial cells carrying the KQ genotype showed, as compared to KK cells, reduced insulin-mediated insulin receptor autophosphorylation (P=0.03), Ser-Akt phosphorylation (P=0.03), and NO synthase activity (P=0.003). CONCLUSIONS-: Our data suggest that the ENPP1 Q121 variant is associated with increased PP in vivo and reduced insulin signaling and ED in vitro, thus indicating a possible pathogenic mechanism for the increased cardiovascular risk observed in ENPP1 Q121 carriers.

Original languageEnglish
Pages (from-to)1678-1683
Number of pages6
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume29
Issue number10
DOIs
Publication statusPublished - Oct 2009

Fingerprint

Nitric Oxide Synthase
Endothelial Cells
Insulin
Blood Pressure
Insulin Resistance
Insulin Receptor
Biological Availability
Meta-Analysis
Nitric Oxide
Genotype
Phosphorylation
In Vitro Techniques

Keywords

  • Arterial stiffness
  • Cardiovascular disease
  • Endothelial dysfunction
  • ENPP-1 gene
  • Insulin resistance

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells. / Bacci, Simonetta; Di Paola, Rosa; Menzaghi, Claudia; Di Fulvio, Patrizia; Di Silvestre, Sara; Pellegrini, Fabio; Baratta, Roberto; Marucci, Antonella; Mastroianno, Sandra; Fini, Grazia; Formoso, Gloria; Consoli, Agostino; Perticone, Francesco; Frittitta, Lucia; Pandolfi, Assunta; Trischitta, Vincenzo.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 29, No. 10, 10.2009, p. 1678-1683.

Research output: Contribution to journalArticle

Bacci, Simonetta ; Di Paola, Rosa ; Menzaghi, Claudia ; Di Fulvio, Patrizia ; Di Silvestre, Sara ; Pellegrini, Fabio ; Baratta, Roberto ; Marucci, Antonella ; Mastroianno, Sandra ; Fini, Grazia ; Formoso, Gloria ; Consoli, Agostino ; Perticone, Francesco ; Frittitta, Lucia ; Pandolfi, Assunta ; Trischitta, Vincenzo. / ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2009 ; Vol. 29, No. 10. pp. 1678-1683.
@article{320dc056199d4b35b7e7b7a6a2e08c1e,
title = "ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells",
abstract = "OBJECTIVE-: Insulin resistance induces increased pulse pressure (PP), endothelial dysfunction (ED), and reduced bioavailability of endothelium-derived nitric oxide (NO). The genetic background of these 3 cardiovascular risk factors might be partly common. The ENPP1 K121Q polymorphism is associated with insulin resistance and cardiovascular risk. METHODS AND RESULTS-: We investigated whether the K121Q polymorphism is associated with increased PP in white Caucasians and with ED in vitro. In 985 individuals, (390 unrelated and 595 from 248 families), the K121Q polymorphism was associated with PP (P=8.0×10). In the families, the Q121 variant accounted for 0.08 of PP heritability (P=9.4×10). This association was formally replicated in a second sample of 475 individuals (P=2.6×10) but not in 2 smaller samples of 289 and 236 individuals (P=0.49 and 0.21, respectively). In the individual patients' data meta-analysis, comprising 1985 individuals, PP was associated with the Q121 variant (P=1.2×10). Human endothelial cells carrying the KQ genotype showed, as compared to KK cells, reduced insulin-mediated insulin receptor autophosphorylation (P=0.03), Ser-Akt phosphorylation (P=0.03), and NO synthase activity (P=0.003). CONCLUSIONS-: Our data suggest that the ENPP1 Q121 variant is associated with increased PP in vivo and reduced insulin signaling and ED in vitro, thus indicating a possible pathogenic mechanism for the increased cardiovascular risk observed in ENPP1 Q121 carriers.",
keywords = "Arterial stiffness, Cardiovascular disease, Endothelial dysfunction, ENPP-1 gene, Insulin resistance",
author = "Simonetta Bacci and {Di Paola}, Rosa and Claudia Menzaghi and {Di Fulvio}, Patrizia and {Di Silvestre}, Sara and Fabio Pellegrini and Roberto Baratta and Antonella Marucci and Sandra Mastroianno and Grazia Fini and Gloria Formoso and Agostino Consoli and Francesco Perticone and Lucia Frittitta and Assunta Pandolfi and Vincenzo Trischitta",
year = "2009",
month = "10",
doi = "10.1161/ATVBAHA.109.189191",
language = "English",
volume = "29",
pages = "1678--1683",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells

AU - Bacci, Simonetta

AU - Di Paola, Rosa

AU - Menzaghi, Claudia

AU - Di Fulvio, Patrizia

AU - Di Silvestre, Sara

AU - Pellegrini, Fabio

AU - Baratta, Roberto

AU - Marucci, Antonella

AU - Mastroianno, Sandra

AU - Fini, Grazia

AU - Formoso, Gloria

AU - Consoli, Agostino

AU - Perticone, Francesco

AU - Frittitta, Lucia

AU - Pandolfi, Assunta

AU - Trischitta, Vincenzo

PY - 2009/10

Y1 - 2009/10

N2 - OBJECTIVE-: Insulin resistance induces increased pulse pressure (PP), endothelial dysfunction (ED), and reduced bioavailability of endothelium-derived nitric oxide (NO). The genetic background of these 3 cardiovascular risk factors might be partly common. The ENPP1 K121Q polymorphism is associated with insulin resistance and cardiovascular risk. METHODS AND RESULTS-: We investigated whether the K121Q polymorphism is associated with increased PP in white Caucasians and with ED in vitro. In 985 individuals, (390 unrelated and 595 from 248 families), the K121Q polymorphism was associated with PP (P=8.0×10). In the families, the Q121 variant accounted for 0.08 of PP heritability (P=9.4×10). This association was formally replicated in a second sample of 475 individuals (P=2.6×10) but not in 2 smaller samples of 289 and 236 individuals (P=0.49 and 0.21, respectively). In the individual patients' data meta-analysis, comprising 1985 individuals, PP was associated with the Q121 variant (P=1.2×10). Human endothelial cells carrying the KQ genotype showed, as compared to KK cells, reduced insulin-mediated insulin receptor autophosphorylation (P=0.03), Ser-Akt phosphorylation (P=0.03), and NO synthase activity (P=0.003). CONCLUSIONS-: Our data suggest that the ENPP1 Q121 variant is associated with increased PP in vivo and reduced insulin signaling and ED in vitro, thus indicating a possible pathogenic mechanism for the increased cardiovascular risk observed in ENPP1 Q121 carriers.

AB - OBJECTIVE-: Insulin resistance induces increased pulse pressure (PP), endothelial dysfunction (ED), and reduced bioavailability of endothelium-derived nitric oxide (NO). The genetic background of these 3 cardiovascular risk factors might be partly common. The ENPP1 K121Q polymorphism is associated with insulin resistance and cardiovascular risk. METHODS AND RESULTS-: We investigated whether the K121Q polymorphism is associated with increased PP in white Caucasians and with ED in vitro. In 985 individuals, (390 unrelated and 595 from 248 families), the K121Q polymorphism was associated with PP (P=8.0×10). In the families, the Q121 variant accounted for 0.08 of PP heritability (P=9.4×10). This association was formally replicated in a second sample of 475 individuals (P=2.6×10) but not in 2 smaller samples of 289 and 236 individuals (P=0.49 and 0.21, respectively). In the individual patients' data meta-analysis, comprising 1985 individuals, PP was associated with the Q121 variant (P=1.2×10). Human endothelial cells carrying the KQ genotype showed, as compared to KK cells, reduced insulin-mediated insulin receptor autophosphorylation (P=0.03), Ser-Akt phosphorylation (P=0.03), and NO synthase activity (P=0.003). CONCLUSIONS-: Our data suggest that the ENPP1 Q121 variant is associated with increased PP in vivo and reduced insulin signaling and ED in vitro, thus indicating a possible pathogenic mechanism for the increased cardiovascular risk observed in ENPP1 Q121 carriers.

KW - Arterial stiffness

KW - Cardiovascular disease

KW - Endothelial dysfunction

KW - ENPP-1 gene

KW - Insulin resistance

UR - http://www.scopus.com/inward/record.url?scp=70349574150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349574150&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.109.189191

DO - 10.1161/ATVBAHA.109.189191

M3 - Article

C2 - 19679831

AN - SCOPUS:70349574150

VL - 29

SP - 1678

EP - 1683

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 10

ER -